Month: September 2020

ROCKVILLE, Md., Sept. 09, 2020 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company’s management will present an overview and update, as well as host investor meetings, at the Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16, 2020, at 2:00 p.m. ET. Investors interested in arranging a virtual meeting with the Company’s management during this conference should contact the conference coordinator.A live webcast of the presentation can be accessed by visiting Events & Presentations in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay of this webcast will...

TORONTO, Sept. 09, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that management will present an update on the Company’s business at the Cantor Virtual Global Healthcare Conference on Thursday, September 17, 2020, at 11:20 a.m. Eastern Time via webcast.The presentation will be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section.About Profound Medical Corp.Profound is a commercial-stage medical device company that develops and markets customizable,...

NOT FOR DISTRIBUTION INTO THE UNITED STATES OR TO UNITED STATES WIRE SERVICESEDMONTON, Alberta, Sept. 09, 2020 (GLOBE NEWSWIRE) — Capital Power Corporation (“Capital Power”) (TSX:CPX) announced today that it has priced a public offering in Canada of unsecured medium term notes in the aggregate principal amount of C$350 million (the “Offering”). The notes have a coupon rate of 3.147% and mature on October 1, 2032.The Offering is expected to close on or about October 1, 2020.Capital Power also announced that it will redeem on October 9, 2020 all of its outstanding 5.276% medium term notes, due November 16, 2020, in the aggregate principal amount of C$251,181,000 (the “November 2020 Notes”). The redemption price will be C$1,025.61 per C$1,000 principal amount of the November 2020 Notes (representing in aggregate C$257,614,750.13) including...

HOUSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) — CBTX, Inc. (Nasdaq: CBTX), or the Company, the bank holding company for CommunityBank of Texas N.A., today announced the resumption of its share repurchase program. The share repurchase program that commenced in July of 2019 allows for the repurchase of up to $40 million of the Company’s common stock through September 30, 2020. Repurchases under this program were temporarily suspended in March of 2020 in light of the uncertainties presented by the COVID-19 pandemic and surrounding events. The Company further announced that its Board of Directors authorized a new share repurchase program under which the Company may repurchase up to $40 million of the Company’s common stock beginning after the close of business on September 30, 2020 through September 30, 2021.Repurchases under the existing...

NEW HAVEN, Conn., Sept. 09, 2020 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™ (nalbuphine ER) to treat serious neurologically mediated conditions, today announced that management will present a Company overview, as well as host virtual investor meetings, at the 2020 H.C. Wainwright Global Investment Conference on September 16, 2020:Presentation Time: 3:00 p.m. ETA live webcast of the presentation can be accessed by visiting ‘News & Events’ in the ‘Investors & News’ section on the Company’s website at www.trevitherapeutics.com. An archived replay of the webcast will also be available for 30 days on the Company’s website following the conference.The Company’s corporate presentation is posted...

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) — HighCape Capital Acquisition Corp. (the “Company”) today announced the closing of its initial public offering of 11,500,000 units at a price of $10.00 per unit, including 1,500,000 units issued pursuant to the exercise by the underwriter of its over-allotment option in full. The units are listed on the Nasdaq Capital Market (“Nasdaq”) and began trading under the ticker symbol “CAPAU” on September 4, 2020. Each unit consists of one share of Class A common stock and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50 per share. After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “CAPA” and...

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, announced today that the Company will participate in the CL King Best Ideas Conference, to be hosted virtually on Wednesday, September 16th, 2020.The Company’s discussion is scheduled to begin at 10:15 AM (ET) on Wednesday, September 16th, 2020. A live audio webcast may be accessed in the ‘Investors’ section of the Company’s website, located at www.abm.com, and an archive will also be available on the ABM website for 90 days.ABOUT ABMABM (NYSE: ABM) is a leading provider of facility solutions with revenues of approximately $6.5 billion and approximately 140,000 employees in 350+ offices throughout the United States and various international locations. ABM’s comprehensive capabilities include janitorial, electrical &...

OSLO, Norway, Sept. 09, 2020 (GLOBE NEWSWIRE) — Opera Limited (NASDAQ: OPRA), one of the world’s major browser developers and a leading internet consumer brand, announced today that Frode Jacobsen, Chief Financial Officer, and Derrick Nueman, Vice President of Investor Relations, will present and host one-on-one investor meetings at the Key Banc Future of Technology Series.Event Details:Key Banc Future of Technology Series Date: Wednesday, September 16, 2020Virtual Presentation: 12:40 p.m. ETA webcast of the presentations will be available on Opera’s investor relations website at https://investor.opera.com.About OperaOpera is a leading global internet brand with an engaged and growing base of over 360 million average monthly active users. Building on over 20 years of innovation, starting with our browser products, we are increasingly...

CALGARY, Alberta, Sept. 09, 2020 (GLOBE NEWSWIRE) — Toscana Energy Income Corporation (Toscana) (TSX: TEI) is pleased to announce that it has scheduled its annual and special meeting for October 27, 2020 at 9:00 a.m. (Calgary time) (the Meeting). As previously announced by Toscana, the Meeting is being called to consider, among other annual matters of business, the previously announced transaction (the Arrangement) with i3 Energy plc (i3 Energy), an AIM-listed oil and gas company, pursuant to which i3 Energy will acquire all of the issued and outstanding common shares in the capital of Toscana pursuant to the terms of an arrangement agreement between Toscana and i3 Energy dated June 23, 2020 (the Arrangement Agreement). In furtherance of the foregoing, Toscana and i3 Energy entered into an amending agreement to the Arrangement Agreement...

WIXOM, Mich., Sept. 09, 2020 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it has entered into an exclusive license agreement with Jeil Pharmaceutical Co., Ltd. (“Jeil”), for the rights to commercialize Triferic (ferric pyrophosphate citrate) in South Korea.Under the terms of the license agreement, Jeil will be the exclusive development and commercialization partner for Triferic in South Korea and Rockwell Medical will supply the product to Jeil. In consideration for the license, Rockwell Medical will receive an upfront fee and will be eligible for milestone payments and royalties on net sales.Jeil...